Effect of MP‐AzeFlu compared to monotherapy on COX‐2, PGE2, and EP2 gene expression in upper airway mucosa
暂无分享,去创建一个
J. Mullol | J. Roca‐Ferrer | I. Alobid | M. Fuentes | Ferdinand Kopietz | A. Valero | V. Tubita | Sonia Vicens‐Artes | D. Nguyen
[1] W. Zou,et al. A comprehensive gene expression profile of allergic rhinitis-derived nasal fibroblasts and the potential mechanism for its phenotype , 2022, Human & experimental toxicology.
[2] A. Peters,et al. Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches , 2021, Allergy.
[3] J. Bousquet,et al. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review , 2021, International Archives of Allergy and Immunology.
[4] A. Peters,et al. Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches , 2021, Allergy.
[5] Shengwen Shao,et al. Interleukin-17A up-regulates thymic stromal lymphopoietin production by nasal fibroblasts from patients with allergic rhinitis , 2020, European Archives of Oto-Rhino-Laryngology.
[6] A. Peters,et al. Utilizing Endotypes, Phenotypes, and Inflammatory Markers to Guide Treatment Decisions in Chronic Rhinosinusitis. , 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[7] Byung Guk Kim,et al. Effect of fluticasone propionate on human nasal fibroblasts exposed to urban particulate matter. , 2019, Auris, nasus, larynx.
[8] P. Hellings,et al. MP29‐02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite‐allergic rhinitis , 2018, Allergy.
[9] S. Durham,et al. Pathogenesis of rhinitis , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[10] J. Wilson,et al. The Role of the Fibroblast in Inflammatory Upper Airway Conditions. , 2016, The American journal of pathology.
[11] J. Bousquet,et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. , 2012, The Journal of allergy and clinical immunology.
[12] J. Mullol,et al. Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. , 2011, The Journal of allergy and clinical immunology.
[13] F. Hampel,et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[14] Degeng Wang,et al. Discrepancy between mRNA and protein abundance: Insight from information retrieval process in computers , 2008, Comput. Biol. Chem..
[15] J. Mullol,et al. Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease. , 2016, The Journal of allergy and clinical immunology.
[16] I. Um,et al. Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system , 2015, Scientific Reports.